Brief: Encompass Health Q4 Adjusted EPS USD 1.17 Vs. IBES Estimate USD 1.03
Feb 06 (Reuters) - Encompass Health Q4 adjusted EBITDA USD 289.6 million vs. IBES estimate USD 270.8 million. * Q4 adjusted free cash flow USD 190.5 million * Q4 operating revenue USD 1,405 million vs. IBES estimate USD 1,381 million
Recent news on Encompass Health
See all newsBrief: Encompass Health Issues Notice For Partial Redemption Of Its 4.500% Senior Notes Due 2028
Brief: Encompass Health Announces Pricing Of $500 Million Of Senior Notes Due 2034 In A Private Offering
Brief: Encompass Health Announces Private Offering Of Senior Notes
Brief: Encompass Health Announces Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In Post Falls, Idaho
Brief: Encompass Health Declares Dividend On Common Stock